98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ptj/pzac130 | DOI Listing |
Arch Esp Urol
August 2025
Department of Urology, National Taiwan University Hospital, 10002 Taipei, Taiwan.
Objective: Conventional penile venous surgery for erection restoration and surgery for penile augmentation have been controversial. Based on de novo penile fibrovascular assembly, we report innovative penile venous stripping (PVS) and factual penile girth enhancement (FPGE).
Methods: From 2013 to 2023, refractory impotence and dysmorphia prompted 31 patients to seek PVS and FPGE, and all of them were confirmed with veno-occlusive dysfunction.
Ann Vasc Surg
September 2025
CETI, 8 rue de Duras, 75008 Paris, France.
Objective: Assess results of simultaneous ligation and embolization for caverno-venous leakage (CVL) in patients with erectile dysfunction (ED) resistant to 5-Phosphodiesterase inhibitors.
Patients And Methods: Data from consecutive patients with ED operated-on for CVL, were collected prospectively. CVLs were diagnosed by Pharmacologicaly-Challenged Penile Duplex Sonography (PC-PDS) and computed tomography cavernosography.
BMC Urol
August 2025
Istanbul Faculty of Medicine, Department of Urology, Section of Andrology, Istanbul, Türkiye.
Background: The outcomes of clinical trials on stem cell therapy (SCT) on erectile dysfunction (ED) treatment are promising but there is still no conclusive evidence regarding its efficacy. The aim of this meta-analysis is to compile studies that assess the effectiveness of SCT on ED to reach a more reliable conclusion.
Methods: The meta-analysis was registered to PROSPERO (CRD42024540511).
Andrology
August 2025
Division of Surgery and Interventional Science, University College London, London, UK.
Background And Objective: The Current European Association of Urology guidelines do not provide recommendation for combination of regenerative therapies with standard therapies for erectile dysfunction. The aim of this study was to compare the efficacy of combined regenerative therapy with monotherapy for erectile dysfunction.
Methods: A systematic review and meta-analysis were conducted following the 2020 Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines.
Zhonghua Nan Ke Xue
June 2025
School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu 211198, China.
Objective: To assess the safety, efficacy and potential impact of stem cell therapy (SCT) in improving erectile dysfunction (ED).
Methods: A comprehensive search strategy was used to search the literatures on safety and efficacy evaluation of stem cell (SC) in the treatment of ED by human clinical trials from PubMed, Embase and Web of science databases with a search time frame from database creation to July 4, 2024. The exclusion criteria were as follows: reviews, conference abstracts, animal experiments, and duplicate sample literature.